A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies.



Study Overview

The main purpose of this study is to find out if a new drug called E2027 works in people who have Dementia with Lewy Bodies (DLB).


Study Description

The main purpose of this study is to find out if a new drug called E2027 works in people who have Dementia with Lewy Bodies (DLB).

Additional Information:

Participants will be paid for their participation.



Research Study Identifier: NCT03467152
ClinicalTrials.gov Identifier: NCT1805643252
Principal Investigator: Jared Brosch, MD


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.